BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19217918)

  • 1. Baclofen, raclopride, and naltrexone differentially affect intake of fat/sucrose mixtures under limited access conditions.
    Wong KJ; Wojnicki FH; Corwin RL
    Pharmacol Biochem Behav; 2009 May; 92(3):528-36. PubMed ID: 19217918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen, raclopride, and naltrexone differentially affect intake of fat and sucrose under limited access conditions.
    Corwin RL; Wojnicki FH
    Behav Pharmacol; 2009 Sep; 20(5-6):537-48. PubMed ID: 19724193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.
    Rao RE; Wojnicki FH; Coupland J; Ghosh S; Corwin RL
    Pharmacol Biochem Behav; 2008 Jun; 89(4):581-90. PubMed ID: 18353432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baclofen suppresses binge eating of pure fat but not a sugar-rich or sweet-fat diet.
    Berner LA; Bocarsly ME; Hoebel BG; Avena NM
    Behav Pharmacol; 2009 Oct; 20(7):631-4. PubMed ID: 19752722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
    Avena NM; Bocarsly ME; Murray S; Gold MS
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):460-7. PubMed ID: 25069013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen reduces fat intake under binge-type conditions.
    Buda-Levin A; Wojnicki FH; Corwin RL
    Physiol Behav; 2005 Sep; 86(1-2):176-84. PubMed ID: 16140347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen-induced reductions in optional food intake depend upon food composition.
    Wojnicki FH; Charny G; Corwin RL
    Appetite; 2013 May; 64():62-70. PubMed ID: 23321345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
    Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet.
    Baker RW; Osman J; Bodnar RJ
    Pharmacol Biochem Behav; 2001; 69(1-2):201-8. PubMed ID: 11420087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesogenic diets may differentially alter dopamine control of sucrose and fructose intake in rats.
    Pritchett CE; Hajnal A
    Physiol Behav; 2011 Jul; 104(1):111-6. PubMed ID: 21549729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Aminobutyric acid receptor subtype antagonists differentially alter opioid-induced feeding in the shell region of the nucleus accumbens in rats.
    Znamensky V; Echo JA; Lamonte N; Christian G; Ragnauth A; Bodnar RJ
    Brain Res; 2001 Jul; 906(1-2):84-91. PubMed ID: 11430864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the ability of baclofen to reduce fat intake in rats.
    Wojnicki FH; Brown SD; Corwin RL
    Behav Pharmacol; 2014 Apr; 25(2):166-72. PubMed ID: 24569221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.
    Khaimova E; Kandov Y; Israel Y; Cataldo G; Hadjimarkou MM; Bodnar RJ
    Brain Res; 2004 Nov; 1026(2):284-94. PubMed ID: 15488491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat emulsion composition alters intake and the effects of baclofen.
    Wang Y; Wilt DC; Wojnicki FH; Babbs RK; Coupland JN; Corwin RL
    Appetite; 2011 Dec; 57(3):628-34. PubMed ID: 21855586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental area region of rats.
    Echo JA; Lamonte N; Ackerman TF; Bodnar RJ
    Physiol Behav; 2002 May; 76(1):107-16. PubMed ID: 12175594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of baclofen on operant performance for food pellets and vegetable shortening after a history of binge-type behavior in non-food deprived rats.
    Wojnicki FH; Roberts DC; Corwin RL
    Pharmacol Biochem Behav; 2006 Jun; 84(2):197-206. PubMed ID: 16782181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variance contributes to dopamine receptor antagonist-induced inhibition of sucrose intake in inbred and outbred mouse strains.
    Dym CT; Pinhas A; Robak M; Sclafani A; Bodnar RJ
    Brain Res; 2009 Feb; 1257():40-52. PubMed ID: 19135035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake.
    Minnaard AM; Ramakers GMJ; Vanderschuren LJMJ; Lesscher HMB
    Behav Pharmacol; 2021 Apr; 32(2&3):251-257. PubMed ID: 33315615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lisdexamfetamine in a rat model of binge-eating.
    Vickers SP; Hackett D; Murray F; Hutson PH; Heal DJ
    J Psychopharmacol; 2015 Dec; 29(12):1290-307. PubMed ID: 26589243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of flavor preference conditioning in sham-feeding rats: effects of dopamine receptor antagonists.
    Yu WZ; Silva RM; Sclafani A; Delamater AR; Bodnar RJ
    Pharmacol Biochem Behav; 2000 Apr; 65(4):635-47. PubMed ID: 10764916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.